-
MindMed To Begin Clinical Trials On Ayahuasca's Active Ingredient DMT
Thursday, June 18, 2020 - 7:30am | 513Biopharmaceutical and psychedelics research company Mind Medicine Inc. (NEO:MMED) (OTC: MMEDF) announced Thursday that it will begin studying DMT’s effects on humans in a Phase 1 clinical trial conducted in collaboration with University Hospital Basel in Switzerland. Understanding The...